Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201204071 Principal Investigator: Wagner-Johnston, Nina
Title: A Phase I/II Institutional Study of Abraxane in Recurrent and Refractory Lymphoma
Phase: I/II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find the maximum tolerated dose for Abraxane as well as discover what side effects are associated with its use in patients with lymphoma and how the disease responds to Abraxane.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)